2021
Clinical cancer research

First-in-human study of the biodistribution and pharmacokinetics of [sup](89)Zr-CX-072, a novel immunopet tracer based on an anti-PD-L1 probody

View Publication
Details

Authors:
Olga Vasiljeva
Title of the Article:
First-in-human study of the biodistribution and pharmacokinetics of [sup](89)Zr-CX-072, a novel immunopet tracer based on an anti-PD-L1 probody
Journal:
Clinical cancer research
Year of Publication:
2021
Pages:
str. 5325-5333
Volume and Issue Number:
vol. 27, no. 19
ISSN Number:
1078-0432
DOI (Digital Object Identifier):
10.1158/1078-0432.CCR-21-0453
COBISS ID:
82089219
COBISS
Download PDF
Researchers

Researchers

Meet our dedicated researchers behind this publication:

Olga Vasiljeva

References

References & Citations

Upload File Icon - Laboratory X Webflow Template

Access paper

Access the PDF publication document.

Download PDF
More documentation

Related publications

Browse all publications
2016
2016
Biochimie

In vivo imaging of protease activity by Probody therapeutic activation

Olga Vasiljeva

10.1016/j.biochi.2015.11.003

Learn more
2017
2017
Theranostics

Non-invasive in vivo imaging of tumour-associated cathepsin B by a highly selective inhibitory DARPin

Dr. Janja Završnik; Dušan Turk; Olga Vasiljeva; Prof Vito Turk 44bff; Prof. Vito Turk; Boris Turk

10.7150/thno.19081

Learn more
2017
2017
Oncotarget

Cystatin C deficiency suppresses tumor growth in a breast cancer model through decreased proliferation of tumor cells

Dr. Janja Završnik; Dr. Miha Butinar; Mojca Trstenjak Prebanda; Aleksander Krajnc; Robert Vidmar; Marko Fonović; Prof Vito Turk 44bff; Prof. Vito Turk; Boris Turk; Olga Vasiljeva

10.18632/oncotarget.17379

Learn more

Explore our collection of 200+ Premium Webflow Templates